Nicola Nicolai


Affiliation: Istituto Nazionale Tumori
Country: Italy


  1. Nicolai N, Necchi A, Raggi D, Biasoni D, Catanzaro M, Piva L, et al. Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease. Urology. 2015;85:402-6 pubmed publisher
    ..Risk factors associate with disease behavior, but indications to prophylactic intervention remain controversial. ..
  2. Nicolai N, Sangalli L, Necchi A, Giannatempo P, Paganoni A, Colecchia M, et al. A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings. Clin Genitourin Cancer. 2016;14:323-30 pubmed publisher
    ..The role of perioperative treatment in these patients remains controversial. Some caution in administering preemptive treatment in patients with resectable disease is needed. ..
  3. Trama A, Botta L, Nicolai N, Rossi P, Contiero P, Fusco M, et al. Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study. Eur J Cancer. 2016;67:91-98 pubmed publisher
    ..The increase in survival, with the decrease in mortality, suggests an effect of radical treatments on prognosis. ..
  4. Nicolai N, Miceli R, Necchi A, Biasoni D, Catanzaro M, Milani A, et al. Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence. Eur Urol. 2010;58:912-8 pubmed publisher
    ..2%. Most patients could avoid the immediate and late toxicity of chemotherapy. Prognostic parameters combined into the multivariable model appeared of limited use in identifying a subset of patients at high risk of recurrence. ..
  5. Nicolai N, Colecchia M, Biasoni D, Catanzaro M, Stagni S, Torelli T, et al. Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection. J Urol. 2011;186:1298-302 pubmed publisher
    ..Concordance between original and reviewed reports was generally poor. Reviewed parameters better predicted nodal status at retroperitoneal lymph node dissection. These findings may have important implications in clinical practice. ..
  6. Nicolai N, Tarabelloni N, Gasperoni F, Catanzaro M, Stagni S, Torelli T, et al. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center. J Urol. 2017;: pubmed publisher
    ..Select patients with stage I nonseminomatous germ cell tumor could be offered laparoscopic retroperitoneal lymph node dissection as an alternative to other options. ..
  7. request reprint
    Nicolai N, Necchi A, Piva L, Stagni S, Catanzaro M, Biasoni D, et al. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)]. Urologia. 2010;77:84-7 pubmed